The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients

Abstract Background Prednisone (PDN) in juvenile dermatomyositis (JDM), alone or in association with other immunosuppressive drugs, namely methotrexate (MTX) and cyclosporine (CSA), represents the first-line treatment option for new onset JDM patients. No clear evidence based guidelines are actually...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Gabriella Giancane (Údar), Claudio Lavarello (Údar), Angela Pistorio (Údar), Sheila K. Oliveira (Údar), Francesco Zulian (Údar), Ruben Cuttica (Údar), Michel Fischbach (Údar), Bo Magnusson (Údar), Serena Pastore (Údar), Roberto Marini (Údar), Silvana Martino (Údar), Anne Pagnier (Údar), Christine Soler (Údar), Valda Staņēvicha (Údar), Rebecca Ten Cate (Údar), Yosef Uziel (Údar), Jelena Vojinovic (Údar), Elena Fueri (Údar), Angelo Ravelli (Údar), Alberto Martini (Údar), Nicolino Ruperto (Údar), for the Paediatric Rheumatology International Trials Organisation (PRINTO) (Údar)
Formáid: LEABHAR
Foilsithe / Cruthaithe: BMC, 2019-05-01T00:00:00Z.
Ábhair:
Rochtain ar líne:Connect to this object online.
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Ar líne

Connect to this object online.

3rd Floor Main Library

Sonraí sealbhúcháin ó 3rd Floor Main Library
Gairmuimhir: A1234.567
Cóip 1 Ar fáil